Posts filtered by tags: Bayer[x]


 

France takes Roundup weed-killer off market after court ruling

French authorities on Tuesday banned the sale of a form of controversial weed-killer Roundup following a court ruling that regulators failed to take safety concerns into account when clearing the widely used herbicide. Roundup, owned by Germany's Bayer after its purchase of US agro-giant Monsanto last year, contains glyphosate which environmentalists and other critics have long believed causes cancer. The French food and environmental safety agency ANSES said in a statement that sales of Round...
Tags: Science, France, Germany, US, Monsanto, Bayer, ANSES


Macquarie Capital appoints Bayer and Singh as co-heads of industrials in the Americas

Macquarie Capital has named Robert Bayer and Ajay Singh as co-heads of industrials in the Americas. Previously, Bayer worked at Guggenheim Partners, where he was a senior managing director while Singh was at UBS, where he was managing director, global head of chemicals. PRESS RELEASE NEW YORK–(BUSINESS WIRE)–Macquarie Capital, the corporate advisory, capital markets and principal investment arm of Macquarie Group (ASX:MQG; ADR:MQBKY), today announced that it is initiating expanded coverage of th...
Tags: Asia, Japan, UK, New York, Germany, Americas, US, Trends, People, Chicago, Credit Suisse, Ubs, Rob, Bayer, Steven, Jefferies Group


Macquarie Captial appoints Bayer and Singh as co-heads of industrials in the Americas

Macquarie Capital has named Robert Bayer and Ajay Singh as co-heads of industrials in the Americas. Previously, Bayer worked at Guggenheim Partners, where he was a senior managing director while Singh was at Credit Suisse, where he was a director in the firm’s industrials practice. PRESS RELEASE NEW YORK–(BUSINESS WIRE)–Macquarie Capital, the corporate advisory, capital markets and principal investment arm of Macquarie Group (ASX:MQG; ADR:MQBKY), today announced that it is initiating expanded co...
Tags: Asia, Japan, UK, New York, Germany, Americas, US, Trends, People, Chicago, Credit Suisse, Ubs, Rob, Bayer, Steven, Jefferies Group


French court cancels Monsanto weedkiller permit on safety grounds

A French court canceled the license for one of Monsanto's glyphosate-based weedkillers on Tuesday over safety concerns, in the latest blow to the Bayer-owned business. Germany's Bayer, which bought Monsanto for $63 billion last year, faces thousands of U.S. lawsuits by people who say its Roundup and Ranger Pro products caused their cancer. A court in Lyon in southeast France ruled that the approval granted by French environment agency ANSES in 2017 for Roundup Pro 360 had failed to take into a...
Tags: Science, France, Germany, Monsanto, Lyon, Bayer, ANSES


French court annuls market approval for Bayer's RoundUp Pro 360

A French court dealt a blow to Bayer's Monsanto division by deciding to cancel the authorization to market a Monsanto product containing glyphosate. Court filings published on Tuesday showed that a regional French court in Lyon had decided to cancel the market authorization for Monsanto's RoundUp Pro 360.
Tags: Science, Monsanto, Lyon, Bayer


SoftBank spent $900 million in investment banking fees in 2018. The only entity it lagged — the People's Republic of China.

SoftBank spent $900 million in investment banking fees in 2018, more than any company in at least a decade. The People's Republic of China is the only entity to outspend the Japanese tech conglomerate. SoftBank has primarily paid fees to investment bankers to raise capital, but it also executed many high profile investments in companies like WeWork and Cruise Automation. If you didn't have SoftBank as an investment banking client in 2018, you missed out on one of the most massive and lucrativ...
Tags: China, Softbank, Trends, Alibaba, Gm, Citigroup, Deutsche Bank, Silicon Valley, Goldman Sachs, WeWork, Goldman, Coupang, Bayer, Nomura, Republic of China, Masayoshi Son


A small number of banks profited from a SoftBank dealmaking bonanza in 2018 — one of the most lucrative fee opportunities in modern history

SoftBank spent $900 million in investment banking fees in 2018, more than any company in at least a decade. The People's Republic of China is the only entity to outspend the Japanese tech conglomerate. SoftBank has primarily paid fees to investment bankers to raise capital, but it also executed many high profile investments in companies like WeWork and Cruise Automation. If you didn't have SoftBank as an investment banking client in 2018, you missed out on one of the most massive and lucrativ...
Tags: China, Softbank, Trends, Alibaba, Gm, Citigroup, Deutsche Bank, Silicon Valley, Goldman Sachs, WeWork, Goldman, Coupang, Bayer, Nomura, Republic of China, Masayoshi Son


Snap CEO Evan Spiegel claimed Instagram makes you feel ‘terrible’ and Snapchat doesn’t. But data suggests he’s wrong. (SNAP)

Snap CEO Evan Spiegel recently said that Instagram made users feel "terrible" because they had to "compete for popularity." Spiegel has yet to provide any proof to back up this claim, and current research suggests he is wrong. Snapchat does, however, seem to have a slightly better emotional impact on users than Instagram, according to multiple surveys. Assessing the impact of social-media apps on emotional well-being is complicated by factors like "active" versus "passive" use, and timeframe. ...
Tags: Facebook, UK, Instagram, Minnesota, Social Networking, Trends, Snapchat, New York Times, Evan Spiegel, Miranda Kerr, University Of Michigan, Bayer, Ohio State University, University of Minnesota, Royal Society for Public Health, SPIEGEL


Snap CEO Evan Spiegel claimed Instagram makes you feel ‘terrible’ and Snapchat doesn’t. But he can’t prove it and data suggests he’s wrong. (SNAP)

Snap CEO Evan Spiegel recently said that Instagram made users feel "terrible" because they had to "compete for popularity." Spiegel has yet to provide any proof to back up this claim, and current research suggests he is wrong. Snapchat does, however, seem to have a slightly better emotional impact on users than Instagram, according to multiple surveys. Assessing the impact of social-media apps on emotional well-being is complicated by factors like "active" versus "passive" use, and timeframe. ...
Tags: Facebook, UK, Instagram, Minnesota, Social Networking, Trends, Snapchat, New York Times, Evan Spiegel, Miranda Kerr, University Of Michigan, Bayer, Ohio State University, University of Minnesota, Royal Society for Public Health, SPIEGEL


Monsanto Merger Migraine: Safe Or Not, Roundup Is Toxic for Bayer

German multinational Bayer underestimated the risks of acquiring Monsanto. Now, the company is desperately seeking to contain the damage by selling business divisions and cutting jobs. So far, though, none of these moves have helped.
Tags: Monsanto, Bayer


China's approval of DowDuPont soy poses challenge to Bayer

China's approval of imports of a DowDuPont Inc genetically modified soybean puts rival Bayer AG on the defensive, investors and analysts said, as U.S. farmers will have a new choice when planting their most valuable agricultural export. Bayer-owned Monsanto has long dominated the $40 billion U.S. soybean market. The market has opened up, though, as Monsanto's Roundup Ready line of seeds - engineered to tolerate the weed killer glyphosate - has lost effectiveness as weeds develop tolerance ...
Tags: Science, China, Monsanto, Bayer, Bayer AG, DowDuPont Inc


Eli Lilly Makes an $8B Cancer Genetics Bet with Loxo Acquisition

[Updated 1/7/19, 11 a.m. ET. See below.] Eli Lilly is set to acquire Loxo Oncology for approximately $8 billion—a deal that brings to the Indianapolis pharmaceutical giant a class of drugs that treat cancers with particular genetic signatures.Under the agreement announced Monday, Lilly (NYSE: LLY) will pay $235 cash per share of Loxo (NASDAQ: LOXO), which is a 68 percent premium to the Friday closing price of the Stamford, CT, cancer drug developer. Following the news of the deal, shares of Lox...
Tags: Deals, Drugs, Cancer, Trends, Indiana, Indianapolis, Mergers and Acquisitions, Fda, GlaxoSmithKline, Biotech, Life Sciences, Bayer, Clinical Trials, Celgene, American Society of Clinical Oncology, Stamford


U.S. judge stands by ruling to limit evidence in Roundup cancer trials

U.S. District Judge Vince Chhabria during a hearing in San Francisco federal court denied a plaintiff lawyer's request to review the decision, saying trials before him should focus on scientific evidence. Chhabria on Thursday granted Bayer unit Monsanto's request to split an upcoming trial into two phases. The order initially bars lawyers for plaintiff Edwin Hardeman from introducing evidence that the company allegedly attempted to influence regulators and manipulate public opinion.
Tags: Science, San Francisco, Monsanto, Bayer, Chhabria, Vince Chhabria, Edwin Hardeman


U.S. judge limits evidence in trial over Roundup cancer claims

U.S. District Judge Vince Chhabria in San Francisco in an order on Thursday granted Bayer unit Monsanto's request to split an upcoming trial into two phases. The order initially bars lawyers for plaintiff Edwin Hardeman from introducing evidence that the company allegedly attempted to influence regulators and manipulate public opinion. Thursday's order applies to Hardeman's case, which is scheduled to go to trial on Feb. 25, and two other so-called bellwether trials which will help determine t...
Tags: Science, San Francisco, Monsanto, Bayer, HARDEMAN, Vince Chhabria, Edwin Hardeman


How Arsenal missed out on new Chelsea signing Christian Pulisic

It could have been very different for Pulisic Borussia Dortmund star Christian Pulisic signed for Chelsea on Wednesday but it has now been revealed that Arsenal missed the chance to sign him. The American star has been a revelation in the Bundesliga for a couple of years now. Despite being only 20-years-old, it feels as though he has been around for much longer than he has, such is the scale of his rise. Now, his rise is set to continue in the Premier League after it was announced he has joined...
Tags: Germany, Eu, Sport, Soccer, Chelsea, Premier League, Arsenal, Arsene Wenger, Blues, Croatia, Borussia Dortmund, Bayer, Christian Pulisic, Pulisic, Leverkusen, Signal Iduna Park


Chelsea complete deal for Borussia Dortmund’s Christian Pulisic

Chelsea have completed a deal to sign Borussia Dortmund forward Christian Pulisic. The US international joins the Blues in a deal worth €64m but he will return to the Westfalenstadion for the rest of the season. Pulisic has seen his stock significantly rise over the past two-a-half seasons having made a huge impression in Germany. Borussia Dortmund announce Pulisic deal with Chelsea 🤝 @cpulisic_10 wechselt im Sommer zum @ChelseaFC! Der BVB hat sich mit dem FC Chelsea auf einen Transfer von Ch...
Tags: England, Germany, US, Sport, Soccer, Chelsea, Premier League, Manchester United, Tottenham, Christian, Borussia Dortmund, Dortmund, Bayer, Christian Pulisic, Alvaro Morata, Pulisic


Trustbusting is now a bipartisan issue

Ronald Reagan may be sainted by the right, but 2018 was the year conservatives broke with his slavish, simpleminded adherence to the Chicago School antitrust theory that says that governments should only regulate monopolies when they give rise to higher consumer prices -- it's also the year the right realized that extreme market concentration in the tech sector could lead to a future in which conspiracy theorists, Nazis, "white identity enthusiasts," and crank misogynists might find themselves ...
Tags: Google, Amazon, Post, Politics, News, Microsoft, Congress, US, America, Economics, Chicago, Ronald Reagan, Iowa, Antitrust, Monsanto, Federal Reserve


U.S. FDA approves new protocol for study on Bayer's birth control device

The U.S. Food and Drug Administration on Thursday approved a new protocol for a post-marketing study of Bayer AG's Essure birth-control device, as the regulator seeks more information on the device's safety. Bayer said in July it would phase out the birth control product in the United States, a decision which the company said was due to declining sales of the implantable device and not based on safety concerns.
Tags: Science, United States, Fda, Bayer, U S Food and Drug Administration, Bayer AG


The 12 Best Dance Tracks of 2018

None For the third consecutive year, global music sales have flourished, online streaming has become the record industry's most profitable revenue source, and artists are still rarely compensated at an equitable rate exceeding the time and investment they have put into their craft. Nothing revelatory there, but maybe this news points to a possible shift in the pervasiveness of international music piracy. Maybe. On the other hand, festivals continue to draw ire each time someone tragically ove...
Tags: Google, Feature, Music, Hbo, UK, London, Youtube, America, Los Angeles, Dance, Azealia Banks, House, Vogue, Manchester, Sydney, Paul Mccartney


A Silicon Valley startup with 26 patents under its belt just raised $400 million from SoftBank and Goldman Sachs to make materials from living things

On Thursday, the Silicon Valley-based synthetic-biology company Zymergen announced a mammoth funding round of $400 million. It's the third largest biotech deal of 2018. With financing from SoftBank Vision Fund and Goldman Sachs, the fresh infusion of cash brings the startup to the forefront of a hot and growing industry based on manufacturing goods with biology. Zymergen doesn't yet have any consumer-facing products, but CEO Joshua Hoffman told Business Insider they're working on their first: ...
Tags: Boston, Softbank, Trends, San Diego, Silicon Valley, Goldman Sachs, Genomatica, Zymergen, Dfj, Ginkgo Bioworks, Business Insider, Bay Area, Bayer, Don, Hoffman, SoftBank Vision Fund


The Bleeding Edge: a terrifying, enraging look at the corrupt, deadly world of medical implants

Prior to 1976, the FDA did not regulate medical implants, and so shoddy and even deadly devices proliferated, inserted into Americans' body. When the FDA finally decided to regulate implants, they were reluctant to subject the devices already in the field to regulation -- after all, these were already in peoples' bodies. So they enacted rule 501(k), which grandfathered in any devices in the market, and any devices that were "substantially similar" to those devices. This is a loophole that ...
Tags: Videos, Post, Happy Mutants, Video, Usa, Movies, News, Youtube, Bbc, Documentaries, Fda, Johnson, British Medical Journal, Dick, Bayer, Kirby Dick


Thyssenkrupp proposes former Bayer finance chief as CFO

Thyssenkrupp said on Friday it would propose former Bayer finance chief Johannes Dietsch as its chief financial officer, continuing to fill numerous vacant jobs that have been left unfilled following months of crisis.
Tags: Money, businessNews, Bayer, ThyssenKrupp, Johannes Dietsch


A Silicon Valley startup with 20 patents under its belt just raised $400 million from SoftBank and Goldman Sachs to make materials from living things

On Thursday, Silicon Valley-based synthetic biology company Zymergen announced a mammoth funding round of $400 million. It's one of the largest biotech raises in history. With financing from SoftBank Vision Fund and Goldman Sachs, the fresh infusion of cash brings the startup to the forefront of a hot and growing industry based on manufacturing goods with biology. Zymergen doesn't yet have any consumer-facing products, but CEO Joshua Hoffman told Business Insider they're working on their first...
Tags: Boston, Softbank, Trends, San Diego, Silicon Valley, Goldman Sachs, Genomatica, Zymergen, Dfj, Ginkgo Bioworks, Business Insider, Bay Area, Bayer, Don, Hoffman, SoftBank Vision Fund


Amid Lawsuits, Experts Caution More Research Into IUDs Causing Neurological Disorder

Hundreds of women — at present, 856 and counting — have filed lawsuits against German drug company Bayer over the last two years, claiming that the popular IUD Mirena is causing severe neurological side effects. Experts who have been following the case, however, say that more research is needed before a connection can be made between the contraceptive and the disorder.Mirena is a tiny piece of T-shaped plastic that is inserted directly into the uterus as a way to prevent pregnancy. The FDA appr...
Tags: Fashion, Music, United States, Fda, Mayo Clinic, Bayer, Mirena, Deborah Kotz, Rewire News


Exclusive: Activist investor Elliott has stake in Germany's Bayer - sources

Activist investor Elliott has taken a position in Germany's Bayer, adding to the slew of investments the fund has made in German companies, three people familiar with the matter told Reuters on Friday.
Tags: Money, Germany, businessNews, Bayer, Reuters, Elliott


Bayer's German workers mostly spared from Monsanto-related job cuts: labour boss

The lion's share of job cuts from folding U.S. seed maker Monsanto into Bayer's agriculture unit will affect workers outside Germany, the head of Bayer's works council told Reuters.
Tags: Money, Germany, businessNews, Monsanto, Bayer, Bayer s works council


Bio Roundup: ASH Wrap, CRISPR Baby Fallout, Moderna’s Record IPO

The biggest yearly meeting for blood disease research has come and gone, and yet the stories to come out of the American Society of Hematology’s gathering in San Diego represent just a fraction of what happened in biopharma this week.Even if ASH wasn’t on your radar, the CRISPR baby saga—the apparent birth of gene edited twin girls in China that shocked the life sciences world a few weeks ago—rolled on. One massive buyout was signed, and another even bigger one inched closer to being finalized....
Tags: Deals, Startups, China, Ipo, Trends, IPOs, People, Vc, Adhd, San Diego, Astrazeneca, Fda, National, GlaxoSmithKline, Novartis, Ash


OncoMed’s Saga Ends in Reverse Merger with UK-Based Mereo BioPharma

OncoMed Pharmaceuticals attracted hundreds of millions of dollars from investors and pharmaceutical partners with compounds it developed to target cells that drive cancer growth. But after a series of clinical trial stumbles and the dissolution of its drug development alliances over the last two years, OncoMed is now serving as a vehicle for a UK-based company to gain a public listing in the U.S.Redwood City, CA-based OncoMed (NASDAQ: OMED) announced Wednesday an agreement to merge with rare di...
Tags: Deals, UK, London, Ipo, Cancer, San Francisco, Trends, Investing, Ovarian Cancer, Fda, GlaxoSmithKline, Biotech, Pancreatic Cancer, Life Sciences, Bayer, Clinical Trials


Bayer to sell businesses, cut jobs after Monsanto deal

Bayer, the German drugmaker that bought U.S. seed company Monsanto, announced on Thursday the sale of a number of businesses, around 12,000 job cuts and 3.3 billion euros ($3.8 billion) in impairments.
Tags: Money, businessNews, Monsanto, Bayer


Bayer to cut 12,000 jobs after Monsanto takeover

German chemical and pharmaceutical giant Bayer said Thursday it would slash 12,000 jobs in a major restructuring following the mammoth takeover of Monsanto, enabling it to save 2.6 billion euros ($3 billion) a year from 2022. Bayer swallowed Monsanto in one of Germany's biggest ever corporate takeovers at a cost of $63 billion in June. Announcing details of the restructuring, Bayer said it planned to exit its animal health business, in order to concentrate resources on its core businesses of p...
Tags: News, Germany, Monsanto, Bayer